FDA Talks Tough To Tyco, Cites Baxter For QS Lapses In Warning Letters
This article was originally published in The Gray Sheet
Baxter has implemented 100% leak testing as part of its efforts to respond to a recent FDA warning letter that detailed quality systems infractions
You may also be interested in...
Tyco Healthcare Group subsidiary Radionics should stop shipping certain products that FDA believes pose sterility concerns, the agency suggests in a warning letter dated March 8 and released March 26
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.